Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • Enamine and BioSolveIT Launch the World's Largest Searchable Chemical Space for Novel Compound Sourcing

    Feb 8, 2018, 05:03 AM by Michael Croft
    KIEV & SANKT AUGUSTIN, UKRAINE & GERMANY - Feb 8, 2018 - Kiev, Ukraine, and Sankt Augustin, Germany, 08 February 2018. Enamine Ltd., a leading chemical research organization and producer of the world's largest collections of novel building blocks (150,000) and screening compound libraries (2,400,000), and BioSolveIT GmbH, premium provider of medicinal chemistry software, today announced the launch of the 'REAL Space Navigator'
    Full story
  • This New Company Wants To Sequence Your Genome And Let You Share It On A Blockchain

    Feb 7, 2018, 17:40 PM by Michael Croft
    MIT Technology Review | A new startup from George Church, Nebula Genomics, says it will sequence your genome, secure it using a blockchain, and let you earn cryptocurrency by sharing it with pharma companies.
    Full story
  • Scientific Data Doctoring: Could Blockchain Technology Help Stamp It Out?

    Feb 7, 2018, 10:35 AM by Michael Croft

    Bio-IT World Contributed Commentary | Blockchain technology has emerged as a technology that could reduce data falsification in a publicly visible, traceable, perpetual and immutable fashion, and thus help to rebuild trust in science.

    Full story
  • Oxford Nanopore Outlook 2018

    Feb 7, 2018, 09:56 AM by Michael Croft
    Omics! Omics! Blog | Keith Robison gives his thoughts on the recent publication of the human genome sequencing paper focusing on Oxford Nanopore.
    Full story
  • Charles River Makes Investments In High-Throughput Screening Infrastructure

    Feb 6, 2018, 11:00 AM by Michael Croft

    Bio-IT World Brief | Charles River announced a new agreement which grants Charles River commercial access to AstraZeneca’s high-throughput screening and compound management infrastructure.

    Full story
  • Sequencing Human Genome With Pocket-Sized “Nanopore” Device

    Feb 6, 2018, 10:30 AM by Michael Croft
    NIH Director's Blog | A report in Nature Biotechnology highlights the latest advance in DNA sequencing: the sequencing and assembly of a human genome using a pocket-sized device.
    Full story
  • Gut Microbes Combine To Cause Colon Cancer, Study Suggests

    Feb 5, 2018, 10:36 AM by Michael Croft
    The New York Times | Two types of bacteria common in the gut may accelerate the growth of tumors, suggesting new possibilities for diagnosis and prevention.
    Full story
  • Despite Doubters, Moderna Raises $500 Million, Is Now Worth $7 Billion

    Feb 2, 2018, 11:32 AM by Michael Croft
    Forbes | Moderna Therapeutics, a biotechnology firm that is developing drugs that work on a genetic messaging system that is essentially to all living cells, has raised $500 million from a group of new and current investors.
    Full story
  • IBM Brings V100 GPUs To Its Cloud

    Feb 2, 2018, 10:53 AM by Michael Croft
    TOP500 | The popularity of NVIDIA's Tesla V100 GPUs got another boost this week with IBM's announcement that it has added them to its cloud offerings.
    Full story
  • Adaptive Computing Enterprises Launches New Product for HPC Cloud Bursting

    Feb 2, 2018, 10:34 AM by Michael Croft
    NAPLES, FL, UNITED STATES - Feb 2, 2018 - Adaptive Computing announces its new Cloud Solution, Moab/NODUS Cloud Bursting, making HPC cloud strategies more accessible than ever before
    Full story
  • Certara Acquires BaseCase, A Life Sciences Data Visualization Company

    Feb 1, 2018, 11:30 AM by Michael Croft

    Bio-IT World Brief | Certara today announced that it has acquired BaseCase, a data visualization software as a service company who has extensive Health Economics and Outcomes Research expertise and is actively working in the area of market access.

    Full story
  • Atrius Health Leverages Linguamatics NLP to Support Value-Based Care

    Feb 1, 2018, 09:00 AM by Michael Croft
    CAMBRIDGE, UNITED KINGDOM - Feb 1, 2018 -  Natural Language Processing (NLP) text analytics provider Linguamatics today announced the implementation of the Linguamatics Health enterprise NLP platform, powered by I2E, at Atrius Health to identify and extract critical clinical information hidden within unstructured patient data
    Full story
  • Susan Audino, Chair, Cannabis Advisory Panel and Chair, Cannabis Working Group at AOAC International, Joins the Scientific Advisory Board of CloudLIMS

    Feb 1, 2018, 04:27 AM by Michael Croft
    WILMINGTON, DE, US - Feb 1, 2018 - CloudLIMS, a Laboratory Information Management company specialized in offering data management solutions for cannabis testing laboratories, today announced that Dr
    Full story
  • New Knockout and Knockdown Validated Antibodies Are Launched by Creative Diagnostics for Bio-researchers

    Feb 1, 2018, 00:58 AM by Michael Croft
    SHIRLEY, NY - Feb 2, 2018 - As a leading supplier of high quality antibodies validated for use in multiplexed assays, Creative Diagnostics recently announces that it has added new Knockout and Knockdown Validated Antibodies to its existing antibodies portfolio, which are designed according to the scientific needs of global research institutes, universities and biotech and pharmaceutical companies, etc
    Full story
  • The Doctor Responsible For Gene Therapy’s Greatest Setback Is Sounding A New Alarm

    Jan 31, 2018, 14:49 PM by Michael Croft
    MIT Technology Review | Toxic effects seen in animals raise questions about new gene therapies for children.
    Full story
  • Equus Partners with HGST for High Density All-Flash Storage

    Jan 31, 2018, 11:55 AM by Michael Croft
    EDINA, MN, UNITED STATE OF AMERICA - Jan 31, 2018 - Equus Compute Solutions, the largest U.S. manufacturer of custom computer hardware systems to the channel, has partnered with HGST to offer their line of JBOF (Just a Bunch of Flash) All - Flash Storage systems
    Full story
  • Transpacific Biotech Startup Combines Asian Investors And Some Seriously Trendy Science Out Of MIT

    Jan 31, 2018, 10:53 AM by Michael Croft
    ENDPOINTS NEWS | Engine Biosciences plans to integrate AI and machine learning with hands-on lab work in drug development to create a whole new kind of drug development platform.
    Full story
  • Elsevier Welcomes Six Biotech and Pharma Start-ups to The Hive, Supporting the Most Cutting-edge Research in Industry

    Jan 31, 2018, 09:21 AM by Michael Croft
    NEW YORK, NY - Jan 31, 2018 - Elsevier, the global information analytics business specializing in science and health, today announced that six start-up companies have been selected from more than 150 global applicants for The Hive, Elsevier's innovation initiative for biotech and pharmaceutical start-ups
    Full story
  • MR Solutions launches the most advanced Spectrometer for clinical MRI manufacturers

    Jan 31, 2018, 08:36 AM by Michael Croft
    GUILDFORD, UNITED KINGDOM - Jan 31, 2018 - MR Solutions’ latest EVO2+ spectrometer now offers the most advanced levels of functionality and user control for constructors of clinical MRI scanners
    Full story
  • A Biopharma Innovator's Wish List For President Trump

    Jan 30, 2018, 15:47 PM by Michael Croft
    STAT | In his first State of the Union address, the CEO of Alnylam Pharmaceuticals would like to hear President Trump address five key issues to foster the culture of innovation in the pharmaceutical industry.
    Full story
  • «
  • 281 (current)
  • 282
  • 283
  • 284
  • 285
  • 286
  • 287
  • 288
  • 289
  • 290
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy